Latest Asx Trading News

BirdDog Technology Limited has requested suspension of its shares from ASX trading as it prepares to exit the official exchange list, marking a significant shift for the broadcasting technology firm.

Metrics Real Estate Multi-Strategy Fund has released its inaugural annual report, revealing a strong start with $41.9 million profit before tax and distributions of 8.21 cents per unit following a $302.8 million IPO. The Fund’s diversified commercial real estate portfolio spans senior loans, mezzanine debt, and equity investments across Australia and New Zealand.

Corporate Travel Management Limited has delayed its FY25 financial results due to potential revenue recognition adjustments in Europe, prompting a voluntary ASX trading suspension.

Peninsula Energy Limited has had its ASX trading suspension lifted following the completion of a placement and institutional entitlement offer, signaling renewed market activity.

Unibail-Rodamco-Westfield has requested suspension of its securities from the ASX, marking the first step toward its official delisting. This move signals a significant shift for investors and the commercial property sector.

MRG Metals Limited has seen its MRQOD securities suspended from ASX trading pending regulatory compliance, raising questions about the company’s next steps.

Piedmont Lithium Inc. has halted trading on the ASX as it finalises a merger with Sayona Mining Limited, marking a significant restructuring in the lithium mining sector.

Universal Biosensors Inc. has been suspended from ASX trading following the appointment of voluntary administrators, highlighting serious financial distress within the company.

Trading in New World Resources Limited shares has been suspended following compulsory acquisition notices issued by Kinterra Capital, signaling a major ownership shift.

Lincoln Minerals Limited’s LMLO securities have been suspended from ASX quotation due to non-compliance with listing rules, raising questions about the company’s regulatory standing.

Xstate Resources has received pre-approval to acquire a 51% stake in the Diona project, setting the stage for drilling operations and ASX trading resumption by late September.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.